Change of Name

Recorded: 2023-11-29 Pages: 2

Assignor

HUIGENE THERAPEUTICS CO., LTD.

Executed: 2023-01-28

Assignee

HUIDAGENE THERAPEUTICS CO., LTD.

ROOM 1002, BUILDING #7-1, NO. 160 BASHENG ROAD, PUDONG DISTRICT, SHANGHAI, 201203, CHINA

Covered Property (1)

Treatment of RPE65-Associated Eye Diseases and Disorders

Application: 18/047,255 →

Publication: US 2023/0330269

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.